Tibsovo

Tibsovo is an isocitrate dehydrogease-1 (IDH1) inhibitor indicated for patients with a susceptible IDH1 mutation. Joining the team to concept, I helped finalize the campaign imagery with various vendors. I supporting the creative director, and eventually led the team independently for over a year. We completed brochures, CVAs, leave behinds, wallboards, journal ads, journal wraps, convention materials, websites, and more.

Client: Servier (Agios at the time of below designs)        Date: 2017-2019        Work on the brand included: digital, print, web